Innovative Solutions Needed to Enhance HIV Prevention and Treatment Accessibility in the U.S.

Call for Innovative Solutions in HIV Treatment

The National Institutes of Health (NIH), in collaboration with HeroX, is launching a groundbreaking competition aimed at enhancing the delivery and scale-up of long-acting HIV prevention and treatment methods. While there have been remarkable advancements in HIV prevention and treatment, access and uptake remain inconsistent across different populations. Current statistics reveal that around 1.2 million individuals in the United States are living with HIV, with approximately 1 in 8 being unaware of their condition. This underscores an urgent need to devise more effective treatment delivery strategies that extend access and ensure sustained care for all.

Overview of the NIH ARISE-HIV LAUNCH Challenge

The NIH’s Office of AIDS Research (OAR) is spearheading the NIH ARISE-HIV LAUNCH Challenge, calling for innovative implementation science approaches to confront existing barriers faced by those needing HIV care. By partnering with HeroX, renowned for its crowd-sourced solutions and innovative approaches, the platform invites a diverse array of participants—from researchers and healthcare professionals to community advocates—to contribute their ideas and insights.

The challenge aims to identify and elevate promising strategies that can effectively address issues related to long-acting HIV prevention and treatment in real-world settings. Submissions are sought in two distinct phases, allowing for thorough concept development and planning.

Phase 1: Ideation

In the initial phase, participants are encouraged to submit a concept paper (maximum three pages) outlining a potential approach to enhance long-acting HIV treatment and prevention delivery. Notably, submissions are not required to present prototypes, pilot programs, or preliminary data. The aim is to gather community-informed ideas that would improve access and implementation across HIV service delivery systems.

Selected winners from this phase will each be awarded $10,000 in funding, and up to 25 will advance to the second phase of the competition.

Phase 2: Implementation Planning

Winners from Phase 1 will receive dedicated planning support to further refine their proposals. This includes developing comprehensive plans with clear milestones, deliverables, outcome measures, and evaluations to ensure successful implementation of their strategies.

Participation and Submission Details

Individuals interested in participating must register on the official challenge website and submit their concept papers by the deadline: August 6, 2026, at 5 PM EST. This provides a critical opportunity for individuals with relevant experience and views to influence the future of HIV care.

The Role of HeroX

HeroX, known for connecting complex challenges with innovative problem-solvers globally, is facilitating the NIH ARISE-HIV LAUNCH Challenge. The platform serves as a bridge, bringing together diverse minds to tackle pressing health issues, thereby fostering collaborative efforts.

Conclusion

The NIH's ARISE-HIV initiative was launched in 2025 and collaborates with various NIH institutes and centers focusing on utilizing implementation science to combat the HIV epidemic. With calls for innovative solutions now open, there’s a hopeful path forward to enhance accessibility and efficacy in HIV treatment and prevention for those most in need. Together, with creativity and commitment, we can work towards ending the HIV epidemic and improve health outcomes for those affected by this disease.

For more information and to submit entries, visit HeroX.